Erratum: Author correction to Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo [Acta Pharmaceutica Sinica B 11 (2021) 3950-3965].
- Publication date
- 1 August 2023
- Publisher
- eScholarship, University of California